New CDC Director Takes Helm Amid Crisis01/21 06:13

   

   NEW YORK (AP) -- As the coronavirus swept across the globe last year, the 
Centers for Disease Control and Prevention sank into the shadows, undermined by 
some of its own mistakes and stifled by an administration bent on downplaying 
the nation's suffering.

   Now a new CDC director is arriving to a mammoth task: reasserting the agency 
while the pandemic is in its deadliest phase yet and the nation's largest-ever 
vaccination campaign is wracked by confusion and delays.

   "I don't know if the CDC is broken or just temporarily injured," but 
something must be done to bring it back to health, said Timothy Westmoreland, a 
Georgetown University law professor focused on public health.

   The task falls to Dr. Rochelle Walensky, 51, an infectious-diseases 
specialist at Harvard Medical School and Massachusetts General Hospital, who 
was sworn in Wednesday. She takes the helm at a time when the virus's U.S. 
death toll has eclipsed 400,000 and continues to accelerate.

   While the agency has retained some of its top scientific talent, public 
health experts say, it has a long list of needs, including new protection from 
political influence, a comprehensive review of its missteps during the pandemic 
and more money to beef up basic functions like disease tracking and genetic 
analysis.

   Walensky has said one of her top priorities will be to improve the CDC's 
communications with the public to rebuild trust. Inside the agency, she wants 
to raise morale, in large part by restoring the primacy of science and setting 
politics to the side.

   The speed at which she is assuming the job is unusual. In the past, the 
position has generally been unfilled until a new secretary of health and human 
services is confirmed, and that official names a CDC director. But this time, 
the Biden transition team named Walensky in advance, so she could take the 
agency's reins even before her boss is in place.

   Walensky, an HIV researcher, has not worked at the CDC or at a state or 
local health department. But she has emerged as a prominent voice on the 
pandemic, sometimes criticizing certain aspects of the state and national 
response. Her targets have included the uneven transmission-prevention measures 
that were in place last summer and a prominent Trump adviser's endorsement of a 
"herd immunity" approach that would let the virus run free.

   She acknowledged the weaknesses in her resume. "When people write about me 
as the selection for this position, they will say, 'But she has no 
on-the-ground public health experience,'" she said during a podcast with the 
Journal of the American Medical Association.

   The podcast's host, Dr. Howard Bauchner, who is also editor of the journal, 
praised her effusively. "I can't imagine the CDC and the country being luckier 
... mostly just because you can communicate, which is such an important task 
for the head of the CDC," he said.

   Walensky did not respond to interview requests from The Associated Press.

   She will succeed Dr. Robert Redfield, 69, who came to the CDC with a similar 
resume as an outsider from academia. Redfield kept a low profile during his 
first two years in office after being appointed by the Trump administration in 
2018. Veteran CDC scientists handled crises such as a deadly national surge in 
hepatitis A cases among homeless people and illicit drug users, and a 
mysterious spike in severe illnesses in people who vaped electronic cigarettes.

   The agency's handling of the COVID-19 outbreak began in a similar way. Staff 
scientists took the lead, holding regular news conferences to update the public 
on the emerging problem.

   But the agency stumbled in February when a test for the virus sent to states 
proved to be flawed. Then, later in the month, a top CDC infectious-disease 
expert, Dr. Nancy Messonnier, upset the Trump administration by speaking 
frankly at a news conference about the dangers of the virus when President 
Donald Trump was still downplaying it.

   Within weeks, the agency was pushed off stage. Redfield made appearances, 
but he was often a third-tier speaker after remarks dominated by Trump, Vice 
President Mike Pence and others.

   The CDC "has been sidelined, has been maligned, has been a punching bag for 
many politicians in the outgoing administration. And that has had a detrimental 
effect on the agency's ability to fulfill its mission," said Dr. Richard 
Besser, a former CDC official who now heads the Robert Wood Johnson Foundation.

   White House officials also took steps to try to control the CDC's scientific 
reports and the guidance on its website. For instance, the agency removed 
guidance that advised limiting church choir activities even though studies had 
demonstrated the danger of transmission of extended singing indoors. The agency 
also dropped guidance advising that anyone who came into close contact with an 
infected person should get tested --- then re-adopted it after criticism from 
health experts.

   "Folks across the political spectrum have had reason to doubt the veracity 
and accuracy, sometimes, of CDC's messages," said Adriane Casalotti of the 
National Association of County and City Health Officials.

   While public health veterans say they do not know everything that happened 
behind the scenes, they say Redfield apparently failed to stand up for agency 
scientists, declined to contradict Trump and those around him and passively 
allowed the Trump administration to post its messaging on CDC websites.

   "He wasn't willing to resign when it was necessary or to be fired for 
standing up for principle," said David Holtgrave, a former CDC staffer who is 
now dean of the public health school at the State University of New York at 
Albany.

   Redfield declined to be interviewed.

   The pandemic also exposed some CDC failures and weaknesses unrelated to 
politics. The test kit problem was tied to laboratory contamination at the 
agency's Atlanta headquarters --- a sign of sloppiness. The CDC also lost its 
standing as the nation's go-to source for case counts and other measures of the 
epidemic after university researchers and others developed better systems for 
tracking infections.

   Much of that has to do with cycles of funding for the national public health 
system that rise in reaction to a crisis and then fall, hurting efforts to 
prevent the next crisis.

   Last week, Biden said he would ask for $160 billion for vaccinations and 
other public health programs, including an effort to expand the public health 
workforce by 100,000 jobs.

   Georgetown's Westmoreland called for a law or other measure to prohibit 
political appointees from having editorial review of CDC science and to ban 
them from controlling when the agency releases information. He also recommended 
a review of the CDC to determine if the agency's problems can be traced to 
mismanagement by Trump's political appointees or whether there are deeper flaws 
in the organization.

   Some experts suggest that an administration that values science and 
increases funding could restore the CDC to preeminence. Biden has pledged to 
put scientists out front on COVID-19 matters, Besser noted.

   "That's something I think will be fixed on Day One," he said. "One of the 
things that gives me hope is I did not see a large exodus from CDC during this 
past year. I saw professionals doing their jobs. I saw the mental toll they 
were taking, but I did not see them giving up."